
Trevi Therapeutics Inc
TRVINASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$14.32
Day High
$14.56
Day Low
$14.11
Prev. Close
$14.45
VolumeShares traded today.
950.93K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$2.01B
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-43.72
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$16.12
52W LowLowest price over the past 52 weeks.
$5.38
50D MAAverage closing price over the last 50 trading days.
$13.52
200D MAAverage closing price over the last 200 trading days.
$11.35
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-0.1%1M
+2.3%6M
+24.5%YTD
+18.9%1Y
+117.2%About
Nalbuphine, sold under the brand names Nubain among others, is an opioid analgesic which is used in the treatment of pain. It is given by injection into a vein, muscle, or fat.
www.trevitherapeutics.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade TRVI
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.